Want to see HK:8513 full AI Analyst Report?
Top Page
IAG Holdings Limited
(8513)
Select Model
Select Model
Rating:45Neutral
Price Target:
HK$0.31
▲(160.00% Upside)
Action:Reiterated
Date:09/24/26
The score is held down primarily by weak financial quality (still unprofitable and highly leveraged) despite improved cash flow and recovering margins. Technicals also point to a weak trend with only modest momentum. Valuation provides limited support because the company is loss-making (negative P/E) and no dividend yield is available.
Positive Factors
Revenue Growth
Sustained TTM revenue growth indicates improving demand and business activity, providing a stronger base for operating leverage. Continued top-line expansion could support reinvestment, improve fixed-cost absorption, and help the company move its recovery beyond a temporary earnings improvement.
Negative Factors
Elevated Leverage
Rising debt relative to equity increases financial risk and leaves the company more sensitive to earnings volatility. With equity relatively small compared with assets, leverage may constrain future capital allocation and reduce flexibility if the operating recovery weakens or losses persist.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Sustained TTM revenue growth indicates improving demand and business activity, providing a stronger base for operating leverage. Continued top-line expansion could support reinvestment, improve fixed-cost absorption, and help the company move its recovery beyond a temporary earnings improvement.
Read all positive factors
IAG Holdings Limited (8513) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$23.74M
Dividend YieldN/A
Average Volume (3M)29.03K
Price to Earnings (P/E)―
Beta (1Y)-0.47
Revenue Growth84.45%
EPS Growth66.40%
CountryHK
Employees94
SectorHealthcare
Sector Strength45
IndustryMedical - Instruments & Supplies
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding81,845,535
10 Day Avg. Volume69,300
30 Day Avg. Volume29,033
Financial Highlights & Ratios
PEG Ratio0.32
Price to Book (P/B)10.20
Price to Sales (P/S)0.84
P/FCF Ratio64.65
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
IAG Holdings Limited Business Overview & Revenue Model
Company Description
IAG Holdings Limited functions as an investment holding company, primarily focusing on the manufacturing and sale of injection-molded plastic components for single-use medical devices. The company also provides specialized tooling services, involv...
IAG Holdings Limited Financial Statement Overview
Summary
Income Statement
44
Neutral
Balance Sheet
38
Negative
Cash Flow
62
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 22.55M | 18.59M | 10.46M | 9.15M | 13.90M | 19.77M |
| Gross Profit | 3.12M | 3.08M | 44.00K | -730.00K | 170.00K | 3.97M |
| EBITDA | 717.75K | 731.20K | -1.35M | -2.40M | -1.76M | -4.63M |
| Net Income | -406.00K | -612.00K | -2.63M | -6.75M | -3.06M | -7.05M |
Balance Sheet | ||||||
| Total Assets | 13.44M | 8.92M | 8.75M | 10.06M | 16.32M | 20.91M |
| Cash, Cash Equivalents and Short-Term Investments | 2.03M | 1.19M | 1.78M | 1.60M | 3.66M | 5.99M |
| Total Debt | 4.22M | 4.64M | 4.20M | 4.24M | 2.59M | 3.52M |
| Total Liabilities | 11.90M | 7.41M | 6.63M | 7.19M | 7.19M | 10.16M |
| Stockholders Equity | 1.56M | 1.52M | 2.14M | 2.88M | 8.65M | 10.10M |
Cash Flow | ||||||
| Free Cash Flow | 3.61M | 240.52K | -1.24M | -1.25M | -1.37M | 2.92M |
| Operating Cash Flow | 3.73M | 326.29K | -986.00K | -1.19M | -582.00K | 3.16M |
| Investing Cash Flow | -117.41K | -85.76K | -145.00K | 3.00K | -751.00K | -365.00K |
| Financing Cash Flow | -1.72M | -821.13K | 1.31M | 509.00K | -474.00K | -3.19M |
IAG Holdings Limited Technical Analysis
Negative
0.12
Price Trends
0.33
Negative
0.37
Negative
0.57
Negative
Market Momentum
>-0.01
Positive
36.79
Neutral
25.71
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:8513, the sentiment is Negative. The current price of 0.12 is below the 20-day moving average (MA) of 0.34, below the 50-day MA of 0.33, and below the 200-day MA of 0.57, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 36.79 is Neutral, neither overbought nor oversold. The STOCH value of 25.71 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:8513.
IAG Holdings Limited Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
55 Neutral | HK$66.29M | 4.22 | 12.17% | ― | 36.68% | ― | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
46 Neutral | HK$68.64M | 72.08 | 19.79% | 7.69% | 6.13% | ― | |
45 Neutral | HK$23.74M | -9.45 | -26.34% | ― | 84.45% | 66.40% | |
43 Neutral | HK$19.97M | -6.10 | -32.49% | ― | -21.61% | -140.20% |
* Healthcare Sector Average
HK:8513
IAG Holdings Limited
0.30
-0.99
-76.95%
HK:1889
Sanai Health Industry Group Company Limited
0.18
-0.27
-59.11%
HK:2135
Raily Aesthetic Medicine International Holdings Limited
0.12
<0.01
3.48%
HK:6108
New Ray Medicine International Holding Ltd.
0.21
-0.17
-44.74%
HK:8161
MediNet Group Ltd.
0.46
-0.11
-19.30%
HK:8307
Medicskin Holdings Ltd.
0.17
0.03
25.36%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.